Loading...

Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease‐Modifying Antirheumatic Drugs

OBJECTIVE: The objective of this study is to examine the risk of serious infections (SIs) associated with biological disease‐modifying antirheumatic drugs (bDMARDs) compared with conventional synthetic disease‐modifying antirheumatic drugs (csDMARDs) in patients with rheumatoid arthritis (RA). METHO...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:ACR Open Rheumatol
Main Authors: Ozen, Gulsen, Pedro, Sofia, England, Bryant R., Mehta, Bella, Wolfe, Frederick, Michaud, Kaleb
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6858027/
https://ncbi.nlm.nih.gov/pubmed/31777822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr2.11064
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!